Gigoux M, Holmström MO, Zappasodi R, Park JJ, Pourpe S, Bozkus CCimen, Mangarin LMB, Redmond D, Verma S, Schad S et al..
2022.
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.. Sci Transl Med. 14(649):eaba4380.
